Bioorganic and Medicinal Chemistry Letters p. 855 - 861 (2017)
Update date:2022-08-03
Topics:
Qin, Lan-Ying
Ruan, Zheming
Cherney, Robert J.
Dhar, T.G. Murali
Neels, James
Weigelt, Carolyn A.
Sack, John S.
Srivastava, Anurag S.
Cornelius, Lyndon A.M.
Tino, Joseph A.
Stefanski, Kevin
Gu, Xiaomei
Xie, Jenny
Susulic, Vojkan
Yang, Xiaoxia
Yarde-Chinn, Melissa
Skala, Stacey
Bosnius, Ruth
Goldstein, Christine
Davies, Paul
Ruepp, Stefan
Salter-Cid, Luisa
Bhide, Rajeev S.
Poss, Michael A.
As demonstrated in preclinical animal models, the disruption of PI3Kδ expression or its activity leads to a decrease in inflammatory and immune responses. Therefore, inhibition of PI3Kδ may provide an alternative treatment for autoimmune diseases, such as RA, SLE, and respiratory ailments. Herein, we disclose the identification of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent, selective and orally bioavailable PI3Kδ inhibitors. The lead compound demonstrated efficacy in an in vivo mouse KLH model.
View MoreSuzhou Howsine Biological Technology Co.,Ltd(expird)
website:http://www.howsine.com
Contact:86-512-67262751
Address:No 3,Weihua Road ,Suzhou Industrial Park ,Jiangsu ,China.
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Zhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Triumph International Development Limilted
website:http://www.jiashengchem.cn/
Contact:+86-536-7971999
Address:Yinhai Road,Shouguang
Jiangsu King Road New Materials Co., Ltd.
website:http://www.jskingroad.com
Contact:0519-85720726 0519-85720721 13584535752
Address:No.1,Weihua Road,Xinbei District,Changzhou City,Jiangsu Province
Doi:10.1016/j.tet.2012.05.088
(2012)Doi:10.1016/j.jorganchem.2015.12.038
(2016)Doi:10.1021/om300512z
(2012)Doi:10.1002/jhet.1882
(2014)Doi:10.1016/j.tetlet.2012.07.065
(2012)Doi:10.1016/j.ijms.2012.01.005
(2012)